Mohammad Rahmati

1.1k total citations
51 papers, 774 citations indexed

About

Mohammad Rahmati is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mohammad Rahmati has authored 51 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mohammad Rahmati's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer, Lipids, and Metabolism (6 papers) and MicroRNA in disease regulation (5 papers). Mohammad Rahmati is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer, Lipids, and Metabolism (6 papers) and MicroRNA in disease regulation (5 papers). Mohammad Rahmati collaborates with scholars based in Iran, United States and France. Mohammad Rahmati's co-authors include Nosratollah Zarghami, Daniel Potreau, Romain Guinamard, Marie Demion, Patrick Bois, Abolfazl Akbarzadeh, Aurélien Chatelier, Alireza Alihemmati, Hojjatollah Nozad Charoudeh and Bahman Yousefi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Physiology and Scientific Reports.

In The Last Decade

Mohammad Rahmati

49 papers receiving 756 citations

Peers

Mohammad Rahmati
Kwon-Yeon Weon South Korea
Yeon Ju Kim South Korea
Keum‐Jin Yang South Korea
Jie Qiu China
Attya Bhatti Pakistan
Mohammad Rahmati
Citations per year, relative to Mohammad Rahmati Mohammad Rahmati (= 1×) peers Jianwen Mao

Countries citing papers authored by Mohammad Rahmati

Since Specialization
Citations

This map shows the geographic impact of Mohammad Rahmati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Rahmati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Rahmati more than expected).

Fields of papers citing papers by Mohammad Rahmati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Rahmati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Rahmati. The network helps show where Mohammad Rahmati may publish in the future.

Co-authorship network of co-authors of Mohammad Rahmati

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Rahmati. A scholar is included among the top collaborators of Mohammad Rahmati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Rahmati. Mohammad Rahmati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahmati, Mohammad, et al.. (2025). Design, synthesis, and optimization of a novel ternary photocatalyst for degradation of cephalexin antibiotic in aqueous solutions. Scientific Reports. 15(1). 8824–8824. 4 indexed citations
2.
Nejatian, Mohammad, et al.. (2024). Brewers’ spent grain as a functional ingredient in bakery, pasta, and cereal-based products. Future Foods. 10. 100479–100479. 9 indexed citations
3.
Barzegar, Mohsen, et al.. (2024). Utilizing pistachio green hull extract to produce sugar-free muffins with antioxidant and antidiabetic potential. Applied Food Research. 4(2). 100510–100510. 5 indexed citations
4.
Doustvandi, Mohammad Amin, et al.. (2024). Emerging trends in quantum dot-based photosensitizers for enhanced photodynamic therapy in cancer treatment. Journal of Pharmaceutical Investigation. 55(1). 55–90. 7 indexed citations
5.
Vahedian, Vahid, et al.. (2024). Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view. Functional & Integrative Genomics. 24(5). 150–150. 3 indexed citations
6.
Milani, Morteza, et al.. (2024). Targeting key players in lipid biosynthesis for NAFLD and NASH treatment. Cellular and Molecular Biology. 70(10). 117–133.
7.
Nakhjavani, Sattar Akbari, Mohammad Reza Alivand, Nosratollah Zarghami, et al.. (2022). Sensitive and Convenient Detection of miRNA-145 Using a Gold Nanoparticle-HCR Coupled System: Computational and Validations. IEEE Transactions on NanoBioscience. 22(1). 155–162. 11 indexed citations
8.
Mahmoudi, Reza, et al.. (2021). Recombinant immunotoxins development for HER2-based targeted cancer therapies. Cancer Cell International. 21(1). 470–470. 25 indexed citations
9.
10.
Valipour, Behnaz, et al.. (2019). Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells. Advanced Pharmaceutical Bulletin. 9(3). 470–480. 25 indexed citations
11.
Alihemmati, Alireza, et al.. (2018). Regulation and modulation of PTEN activity. Molecular Biology Reports. 45(6). 2869–2881. 57 indexed citations
12.
Hasani, Akbar, et al.. (2016). Enhanced in Vitro Anti-Tumor Activity of 5-Azacytidine by Entrapment into Solid Lipid Nanoparticles. Advanced Pharmaceutical Bulletin. 6(3). 367–375. 5 indexed citations
13.
Akbari, Bahman, Safar Farajnia, Nosratollah Zarghami, et al.. (2016). Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A. Anti-Cancer Drugs. 28(3). 263–270. 9 indexed citations
14.
Akbari, Bahman, Safar Farajnia, Nosratollah Zarghami, et al.. (2016). Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR). Protein Expression and Purification. 127. 8–15. 15 indexed citations
15.
Milani, Morteza, et al.. (2014). Real-Time PCR Detection of 16S rRNA Novel Mutations Associated with Helicobacter pylori Tetracycline Resistance in Iran. Asian Pacific Journal of Cancer Prevention. 15(20). 8883–8886. 24 indexed citations
16.
Mellatyar, Hassan, et al.. (2014). Comparison of Inhibitory Effect of 17-DMAG Nanoparticles and Free 17-DMAG in HSP90 Gene Expression in Lung Cancer. Asian Pacific Journal of Cancer Prevention. 15(20). 8693–8698. 38 indexed citations
17.
Zarghami, Nosratollah, et al.. (2011). Inhibitory Effect Of Zinc, Copper And Selenium On Telomerase Activity In Tumor Tissues And T47D Breast Cancer Cell Line. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Demion, Marie, Romain Guinamard, Antoun El Chemaly, Mohammad Rahmati, & Patrick Bois. (2006). An Outwardly Rectifying Chloride Channel in Human Atrial Cardiomyocytes. Journal of Cardiovascular Electrophysiology. 17(1). 60–68. 16 indexed citations
19.
Guinamard, Romain, Aurélien Chatelier, Marie Demion, et al.. (2004). Functional characterization of a Ca2+‐activated non‐selective cation channel in human atrial cardiomyocytes. The Journal of Physiology. 558(1). 75–83. 127 indexed citations
20.
Corbi, Pierre, Mohammad Rahmati, Adriana Delwail, et al.. (2000). Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation. European Journal of Cardio-Thoracic Surgery. 18(1). 98–103. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026